{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T06:27:14Z","timestamp":1789194434175,"version":"build-2803163510"},"reference-count":67,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Radiation Oncology"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.semradonc.2011.05.004","type":"journal-article","created":{"date-parts":[[2011,9,20]],"date-time":"2011-09-20T05:35:13Z","timestamp":1316496913000},"page":"294-302","source":"Crossref","is-referenced-by-count":81,"title":["Radioembolization for Primary and Metastatic Liver Cancer"],"prefix":"10.1016","volume":"21","author":[{"given":"Khairuddin","family":"Memon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Lewandowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Kulik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahsun","family":"Riaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary F.","family":"Mulcahy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riad","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semradonc.2011.05.004_bib1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","article-title":"Global cancer statistics","volume":"55","author":"Parkin","year":"2005","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.semradonc.2011.05.004_bib2","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1053\/j.gastro.2004.09.011","article-title":"Primary Liver cancer: Worldwide incidence and trends","volume":"127","author":"Bosch","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.semradonc.2011.05.004_bib3","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1200\/JCO.2008.20.7753","article-title":"Hepatocellular carcinoma incidence, mortality, and survival benefits in the United States from 1975 to 2005","volume":"27","author":"Alterkruse","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2011.05.004_bib4","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1097\/01.RVI.0000179815.44868.66","article-title":"90Y microsphere (TheraSphere) treatment for unresectable colorectal cancer metastases of the liver: Response to treatment at targeted doses of 135-150 Gy as measured by [18F]fluorodeoxyglucose positron emission tomography and computed tomographic imaging","volume":"16","author":"Lewandowski","year":"2005","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.semradonc.2011.05.004_bib5","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1053\/jlts.2003.50147","article-title":"A follow-up analysis of the pattern and predictors of dropout from the waiting list for liver transplantation in patients with hepatocellular carcinoma: Implications for the current organ allocation policy","volume":"9","author":"Yao","year":"2003","journal-title":"Liver Transplant"},{"key":"10.1016\/j.semradonc.2011.05.004_bib6","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/lt.20099","article-title":"Drop-out rates of patients with hepatocellular cancer listed for liver transplantation: Outcome with chemoembolization","volume":"10","author":"Maddala","year":"2004","journal-title":"Liver Transplant"},{"key":"10.1016\/j.semradonc.2011.05.004_bib7","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","article-title":"Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis","volume":"334","author":"Mazzaferro","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semradonc.2011.05.004_bib8","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1053\/j.gastro.2010.10.049","article-title":"Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma","volume":"140","author":"Salem","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.semradonc.2011.05.004_bib9","first-page":"969","article-title":"The blood supply of neoplasms in the liver","volume":"30","author":"Breedis","year":"1954","journal-title":"Am J Pathol"},{"key":"10.1016\/j.semradonc.2011.05.004_bib10","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/01.RVI.0000164324.79242.B2","article-title":"Angiographic considerations in patients undergoing liver-directed therapy","volume":"16","author":"Liu","year":"2005","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.semradonc.2011.05.004_bib11","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00270-007-9064-z","article-title":"Radioembolization with (90)y microspheres: Angiographic and technical considerations","volume":"30","author":"Lewandowski","year":"2007","journal-title":"Cardiovasc Interv Radiol"},{"key":"10.1016\/j.semradonc.2011.05.004_bib12","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1053\/j.tvir.2007.08.001","article-title":"Technical aspects of radioembolization with 90Y microspheres","volume":"10","author":"Salem","year":"2007","journal-title":"Tech Vasc Interv Radiol"},{"key":"10.1016\/j.semradonc.2011.05.004_bib13","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ijrobp.2009.10.062","article-title":"Radiation segmentectomy: A novel approach to increase safety and efficacy of radioembolization","volume":"79","author":"Riaz","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2011.05.004_bib14","doi-asserted-by":"crossref","first-page":"S223","DOI":"10.1016\/S1051-0443(07)61790-4","article-title":"Yttrium-90 microspheres: Radiation therapy for unresectable liver cancer","volume":"13","author":"Salem","year":"2002","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.semradonc.2011.05.004_bib15","first-page":"1156","article-title":"Prospective randomized trial of chemoembolization versus intra-arterial injection of 131I-labeled-iodized oil in the treatment of hepatocellular carcinoma","volume":"26","author":"Raoul","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.semradonc.2011.05.004_bib16","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1148\/radiol.2432051246","article-title":"Inoperable hepatocellular carcinoma: Transarterial 188Re HDD-labeled iodized oil for treatment\u2014Prospective multicenter clinical trial","volume":"243","author":"Kumar","year":"2007","journal-title":"Radiology"},{"key":"10.1016\/j.semradonc.2011.05.004_bib17","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1158\/1078-0432.CCR-05-1730","article-title":"Long-term clinical outcome of phase IIb clinical trial of percutaneous injection with holmium-166\/chitosan complex (Milican) for the treatment of small hepatocellular carcinoma","volume":"12","author":"Kim","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.semradonc.2011.05.004_bib18","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1148\/radiol.2242011283","article-title":"Variant hepatic arterial anatomy revisited: Digital subtraction angiography performed in 600 patients","volume":"224","author":"Covey","year":"2002","journal-title":"Radiology"},{"issue":"suppl 1","key":"10.1016\/j.semradonc.2011.05.004_bib19","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1148\/rg.25si055515","article-title":"Yttrium-90 microsphere therapy for hepatic malignancy: Devices, indications, technical considerations, and potential complications","volume":"25","author":"Murthy","year":"2005","journal-title":"Radiographics"},{"key":"10.1016\/j.semradonc.2011.05.004_bib20","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s00270-006-0028-5","article-title":"Right gastric artery embolization prior to treatment with yttrium-90 microspheres","volume":"30","author":"Cosin","year":"2007","journal-title":"Cardiovasc Interv Radiol"},{"key":"10.1016\/j.semradonc.2011.05.004_bib21","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1097\/01.RVI.0000233785.75257.9A","article-title":"Radioembolization with 90yttrium microspheres: A state-of-the-art brachytherapy treatment for primary and secondary liver malignancies: Part 1: Technical and methodologic Considerations","volume":"17","author":"Salem","year":"2006","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.semradonc.2011.05.004_bib22","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2214\/ajr.172.2.9930792","article-title":"Proximal arterioportal shunting associated with hepatocellular carcinoma: Features revealed by dynamic helical CT","volume":"172","author":"Chen","year":"1999","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.semradonc.2011.05.004_bib23","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/BF01084369","article-title":"Partition model for estimating radiation doses from yttrium-90 microspheres in treating hepatic tumours","volume":"23","author":"Ho","year":"1996","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.semradonc.2011.05.004_bib24","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s00259-002-0787-4","article-title":"Evaluating 90Y-glass microsphere treatment response of unresectable colorectal liver metastases By [18F]FDG PET: A comparison with CT or MRI","volume":"29","author":"Wong","year":"2002","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.semradonc.2011.05.004_bib25","first-page":"1892","article-title":"Metabolic response after intraarterial 90Y-glass microsphere treatment for colorectal liver metastases: Comparison of quantitative and visual analyses by 18F-FDG PET","volume":"45","author":"Wong","year":"2004","journal-title":"J Nucl Med"},{"key":"10.1016\/j.semradonc.2011.05.004_bib26","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jvir.2010.10.029","article-title":"Research reporting standards for radioembolization of hepatic malignancies","volume":"22","author":"Salem","year":"2011","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.semradonc.2011.05.004_bib27","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.semradonc.2011.05.004_bib28","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0168-8278(01)00130-1","article-title":"Clinical management of hepatocellular carcinoma","volume":"35","author":"Bruix","year":"2001","journal-title":"J Hepatol"},{"key":"10.1016\/j.semradonc.2011.05.004_bib29","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/cncr.24050","article-title":"Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma: Are response evaluation criteria in solid tumors reliable?","volume":"115","author":"Forner","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.semradonc.2011.05.004_bib30","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1001\/jama.2010.262","article-title":"Imaging response in the primary index lesion and clinical outcomes following transarteial locoregional therapy for hepatocellular carcinoma","volume":"303","author":"Riaz","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.semradonc.2011.05.004_bib31","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1002\/hep.22747","article-title":"Radiologic-pathologic correlation of hepatocellular carcinoma treated with internal radiation using yttrium-90 microspheres","volume":"49","author":"Riaz","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.semradonc.2011.05.004_bib32","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.jhep.2010.10.004","article-title":"Role of the EASL, RECIST, and WHO response guidelines alone or in combination for hepatocellular carcinoma: Radiologic\u2013pathologic correlation","volume":"54","author":"Riaz","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.semradonc.2011.05.004_bib33","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.jvir.2008.05.002","article-title":"Tumor response after yttrium-90 radioembolization for hepatocellular carcinoma: Comparison of diffusion-weighted functional MR imaging with anatomic MR imaging","volume":"19","author":"Rhee","year":"2008","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.semradonc.2011.05.004_bib34","doi-asserted-by":"crossref","first-page":"5734","DOI":"10.1200\/JCO.2009.23.1282","article-title":"Alpha-fetoprotein response after locoregional therapy for hepatocellular carcinoma: Oncologic marker of radiologic response, progression, and survival","volume":"27","author":"Riaz","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2011.05.004_bib35","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/jso.20609","article-title":"Yttrium-90 microspheres (TheraSphere(R)) treatment of unresectable hepatocellular carcinoma: Downstaging to resection, RFA and bridge to transplantation","volume":"94","author":"Kulik","year":"2006","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.semradonc.2011.05.004_bib36","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1111\/j.1600-6143.2009.02695.x","article-title":"A comparative analysis of transarterial downstaging for hepatocellular carcinoma: Chemoembolization versus radioembolization","volume":"9","author":"Lewandowski","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.semradonc.2011.05.004_bib37","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.gastro.2009.09.006","article-title":"Radioembolization for hepatocellular carcinoma using yttrium-90 microspheres: A comprehensive report of long-term outcomes","volume":"138","author":"Salem","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.semradonc.2011.05.004_bib38","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/hep.21980","article-title":"Safety and efficacy of (90)Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis","volume":"47","author":"Kulik","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.semradonc.2011.05.004_bib39","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jvir.2009.10.013","article-title":"Comparison of yttrium-90 radioembolization and transcatheter arterial chemoembolization for the treatment of unresectable hepatocellular carcinoma","volume":"21","author":"Kooby","year":"2010","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.semradonc.2011.05.004_bib40","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1002\/cncr.24884","article-title":"Therapeutic equivalence in survival for hepatic arterial chemoembolization and yttrium 90 microsphere treatments in unresectable hepatocellular carcinoma: A two-cohort study","volume":"116","author":"Carr","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.semradonc.2011.05.004_bib41","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1023\/A:1013569329846","article-title":"Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer","volume":"12","author":"Gray","year":"2001","journal-title":"Ann Oncol"},{"key":"10.1016\/j.semradonc.2011.05.004_bib42","first-page":"216","article-title":"Treatment of unresectable metastatic colorectal carcinoma to the liver with intrahepatic Y-90 microspheres: A dose-ranging study","volume":"2","author":"Goin","year":"2003","journal-title":"World J Nuc Med"},{"key":"10.1016\/j.semradonc.2011.05.004_bib43","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1002\/cncr.24224","article-title":"Radioembolization of colorectal hepatic metastases using yttrium-90 microspheres","volume":"115","author":"Mulcahy","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.semradonc.2011.05.004_bib44","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/sj.bjc.6605770","article-title":"Multi-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastases","volume":"103","author":"Cosimelli","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.semradonc.2011.05.004_bib45","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1200\/JCO.2006.08.7916","article-title":"Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy","volume":"25","author":"Sharma","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2011.05.004_bib46","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1200\/JCO.2010.28.5643","article-title":"Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy","volume":"28","author":"Hendlisz","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2011.05.004_bib47","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/COC.0b013e31815e4557","article-title":"Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: Early results in 148 patients","volume":"31","author":"Kennedy","year":"2008","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.semradonc.2011.05.004_bib48","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/SLA.0b013e3181728a45","article-title":"90Y Radioembolization for metastatic neuroendocrine liver tumors: Preliminary results from a multi-institutional experience","volume":"247","author":"Rhee","year":"2008","journal-title":"Ann Surg"},{"key":"10.1016\/j.semradonc.2011.05.004_bib49","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1148\/radiol.2472062029","article-title":"Unresectable chemorefractory liver metastases: Radioembolization with 90Y microspheres\u2014Safety, efficacy, and survival","volume":"247","author":"Sato","year":"2008","journal-title":"Radiology"},{"key":"10.1016\/j.semradonc.2011.05.004_bib50","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jvir.2007.02.019","article-title":"90Y radioembolization of metastatic breast cancer to the liver: Toxicity, imaging response, survival","volume":"18","author":"Bangash","year":"2007","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.semradonc.2011.05.004_bib51","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.ijrobp.2007.03.056","article-title":"Use of yttrium-90 microspheres in the treatment of unresectable hepatic metastases from breast cancer","volume":"69","author":"Coldwell","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2011.05.004_bib52","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1097\/01.RVI.0000184594.01661.81","article-title":"Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): Safety, tumor response, and survival","volume":"16","author":"Salem","year":"2005","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.semradonc.2011.05.004_bib53","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.ijrobp.2005.12.051","article-title":"Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: Modern USA experience","volume":"65","author":"Kennedy","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2011.05.004_bib54","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1097\/01.RVI.0000161142.12822.66","article-title":"Yttrium 90 resin microspheres for the treatment of unresectable colorectal hepatic metastases after failure of multiple chemotherapy regimens: Preliminary results","volume":"16","author":"Murthy","year":"2005","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.semradonc.2011.05.004_bib55","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/cncr.23339","article-title":"Liver disease induced by radioembolization of liver tumors: Description and possible risk factors","volume":"112","author":"Sangro","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.semradonc.2011.05.004_bib56","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.jvir.2007.07.016","article-title":"Radiation dose limits and liver toxicities resulting from multiple yttrium-90 radioembolization treatments for hepatocellular carcinoma","volume":"18","author":"Young","year":"2007","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.semradonc.2011.05.004_bib57","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.jvir.2008.01.003","article-title":"Biliary sequelae following radioembolization with Yttrium-90 microspheres","volume":"19","author":"Atassi","year":"2008","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.semradonc.2011.05.004_bib58","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1007\/s10620-007-0148-z","article-title":"Fibrosis, portal hypertension, and hepatic volume changes induced by intra-arterial radiotherapy with 90yttrium microspheres","volume":"53","author":"Jakobs","year":"2008","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.semradonc.2011.05.004_bib59","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1245\/s10434-009-0454-0","article-title":"Radiation lobectomy: Preliminary findings of hepatic volumetric response to lobar yttrium-90 radioembolization","volume":"16","author":"Gaba","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.semradonc.2011.05.004_bib60","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1007\/s10620-007-0148-z","article-title":"Fibrosis, portal hypertension, and hepatic volume changes induced by intra-arterial radiotherapy with (90)yttrium microspheres","volume":"53","author":"Jakobs","year":"2008","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.semradonc.2011.05.004_bib61","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/COC.0b013e318168ef65","article-title":"Incidence of radiation pneumonitis after hepatic intra-arterial radiotherapy with yttrium-90 microspheres assuming uniform lung distribution","volume":"31","author":"Salem","year":"2008","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.semradonc.2011.05.004_bib62","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0360-3016(95)00039-3","article-title":"Radiation pneumonitis after selective internal radiation treatment with intraarterial 90yttrium-microspheres for inoperable hepatic tumors","volume":"33","author":"Leung","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2011.05.004_bib63","series-title":"TheraSphere: Yttrium-90 microspheres package insert","year":"2004"},{"key":"10.1016\/j.semradonc.2011.05.004_bib64","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jvir.2007.02.002","article-title":"Gastrointestinal complications associated with hepatic arterial yttrium-90 microsphere therapy","volume":"18","author":"Murthy","year":"2007","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.semradonc.2011.05.004_bib65","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1111\/j.1572-0241.2007.01172.x","article-title":"Gastroduodenal injury after radioembolization of hepatic tumors","volume":"102","author":"Carretero","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.semradonc.2011.05.004_bib66","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.jvir.2007.08.015","article-title":"Hepatic yttrium-90 radioembolotherapy in metastatic colorectal cancer treated with cetuximab or bevacizumab","volume":"18","author":"Murthy","year":"2007","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.semradonc.2011.05.004_bib67","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/hep.23944","article-title":"Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survival","volume":"52","author":"Hilgard","year":"2010","journal-title":"Hepatology"}],"container-title":["Seminars in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053429611000464?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053429611000464?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,15]],"date-time":"2019-06-15T21:30:50Z","timestamp":1560634250000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053429611000464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":67,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S1053429611000464"],"URL":"https:\/\/doi.org\/10.1016\/j.semradonc.2011.05.004","relation":{},"ISSN":["1053-4296"],"issn-type":[{"value":"1053-4296","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}